People / Emilie Battipede
Emilie Battipede

Emilie Battipede

Emilie Battipede is an associate in the Corporate Practice Group in the Austin office of Haynes and Boone, LLP.

Her practice focuses on mergers and acquisitions, private equity, capital markets and securities.

Selected Client Representations:

  • Represented a publicly traded telecommunications provider in connection with $8.7 billion take-private sale to a publicly traded owner and operator of communications businesses.*
  • Represented a publicly traded media company in a $1.5 billion reattribution of assets and liabilities between company groups.*
  • Represented publicly traded holding company in $2.6 billion sale to publicly traded travel company.*
  • Represented publicly traded holding company in $325 million preferred stock private equity investment.*
  • Advised on reporting obligations under the Securities Exchange Act of 1934.
  • Prepared securities filings, including Schedule 13D and Form 4.

*Some of these representations were handled by Emilie prior to joining Haynes and Boone.

Show More
Expand All
  • Included in the "Ones to Watch" category of The Best Lawyers in America, Woodward/White, Inc., 2023


B.A., Texas A&M University, 2015, magna cum laude

J.D., The University of Texas School of Law, 2018, Submissions Editor, The Texas International Law Journal, 2016-2018



New York

Press Release
Haynes Boone Represents Clinigen Limited in Acquisition of Drug Safety Navigator
December 02, 2022

A Haynes and Boone, LLP deal team represented Clinigen Limited in its acquisition of Drug Safety Navigator Inc. (DSN), a specialist pharmacovigilance service provider based in the U.S. A global pharmaceutical services company focused on providing ethical access to medicines, Clinigen said the acquisition enables it to add vital pharmacovigilance capabilities to its services offering for pharmaceut [...]